Metraipolis › archive › dc_aa1fcf3f81ee

Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection — Europe PMC PMID:42758862

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42758862
DOI
10.1080/22221751.2026.2736987
License (as archived)
CC0-1.0
Archived
2026-10-31T06:43:36.374Z
SHA-256 of the archived text
0a3d0e6485383ed354e319b010654264de3583f0579748afceecbb3dd6cb1fb3
Stable URL of this page
https://metraipolis.com/documento/dc_aa1fcf3f81ee

How to cite

Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection — Europe PMC PMID:42758862 — Europe PMC (en), https://europepmc.org/article/MED/42758862 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_aa1fcf3f81ee (Metraipolis archive dc_aa1fcf3f81ee, sha256 0a3d0e6485383ed354e319b010654264de3583f0579748afceecbb3dd6cb1fb3)
BibTeX
@misc{dcaa1fcf3f81ee,
  title = {Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection — Europe PMC PMID:42758862},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42758862},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_aa1fcf3f81ee; sha256 0a3d0e6485383ed354e319b010654264de3583f0579748afceecbb3dd6cb1fb3},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/42758862. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Rabies is a fatal encephalitis caused by viruses in the lyssavirus genus. We previously demonstrated that intraperitoneal administration of a single dose of neutralizing human monoclonal antibody (mAb) F11 can protect mice from fatal lyssavirus infection, post-central nervous system (CNS) invasion. However, the molecular basis of F11 neutralization remains unknown. Here, we use structural and functional analyses to define neutralizing activity of F11 and the related mAb, A6. Cryo-electron microscopy (EM) and negative-stain EM reveal that both mAbs bind Domain III of the glycoprotein G, recognizing a prefusion-specific epitope distinct from previously characterized antibodies including RVC20. Binding stabilizes the prefusion state, blocking membrane fusion. We furthermore found that a single dose of either A6 or RVC20 protected animals from mortality induced by Australian bat lyssavirus (ABLV), while promoting substantial long-term functional recovery. Moreover, A6 similarly protected animals from mortality following infection with a currently circulating wild isolate of rabies virus (RABV). Transcriptomics analysis of brain RNA and protein-based analysis of brain tissue homogenates demonstrated that therapy with A6 broadly reduced expression of neuroinflammatory mediators during the acute phase of infection. Interestingly, infection of animals with a non-lethal attenuated mutant of ABLV resulted in similar neuroinflammation. Thus, a robust neuroinflammatory response to ABLV does not predict mortality. Overall, peripheral therapy with A6 and similar neutralizing mAbs promotes survival and long-term functional recovery from CNS-resident lyssavirus infection in a manner that includes suppression of the G pre- to postfusion transition and modulation of neuroinflammation.

Tema degli esploratori: ricerca e scienza aperta (ricerca Europe PMC «preprint», solo open access).
Pubblicazione: Emerging microbes & infections, 2026 (prima pubblicazione 2026-10-01).
Identificativi: PMID 42758862 · PMCID PMC13637774 · DOI 10.1080/22221751.2026.2736987.
Parole chiave degli autori: Rabies; Monoclonal antibody; Cryoelectron microscopy; Longitudinal; Transcriptomics; Lyssavirus; Bioluminescence Imaging; Pre-clinical Research.
Descrittori MeSH principali: Lyssavirus; Rhabdoviridae Infections; Rabies; Antibodies, Monoclonal; Antibodies, Viral; Antibodies, Neutralizing; Neuroinflammatory Diseases.
Pagina: https://europepmc.org/article/MED/42758862 — https://doi.org/10.1080/22221751.2026.2736987. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-31T06:33:45.682Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.